News 23 May 2026 - 24 May 2026

Lunai Bioworks Heads Into Key Week After Reverse Split, Ongoing Court Battle
···

Lunai Bioworks Heads Into Key Week After Reverse Split, Ongoing Court Battle

Lunai Bioworks closed at $2.26 Friday, down 2.62%, after a 1-for-8 reverse split aimed at regaining Nasdaq compliance. A Delaware magistrate judge granted Lunai expedited discovery over alleged naked short selling. Nasdaq will remain closed Monday for Memorial Day. Lunai continues to face listing deadlines and reported a $2.57 million net loss for the March quarter.
May 24, 2026
Ocugen Shares Flat Ahead of Holiday-Shortened Week for Eye-Therapy Bid
···

Ocugen Shares Flat Ahead of Holiday-Shortened Week for Eye-Therapy Bid

Ocugen shares closed Friday at $1.34 with 3.9 million shares traded, little changed ahead of the Memorial Day break. The company recently closed a $130 million convertible note sale, using $32.7 million to repay debt and reserving the rest for general purposes. Ocugen will present at the Stifel 2026 Virtual Ophthalmology Forum on Tuesday. The company has completed enrollment in two late-stage eye-disease programs.
May 24, 2026
Tenon Medical faces fresh Nasdaq issue ahead of Tuesday
···

Tenon Medical faces fresh Nasdaq issue ahead of Tuesday

Tenon Medical said it no longer meets Nasdaq’s $2.5 million minimum stockholders’ equity rule, triggering a July 6 deadline to submit a compliance plan. TNON closed Friday at $0.7175, up 0.38%, with the next trading session set for Tuesday after the Memorial Day market holiday. Tenon reported $1.895 million in stockholders’ equity as of March 31 and remains under a separate Nasdaq bid-price warning.
May 24, 2026
Viavi Shares Hit Holiday Week After $557M Debt Move
···

Viavi Shares Hit Holiday Week After $557M Debt Move

Viavi Solutions closed Friday at $49.51, up 1.08% but down 3.8% for the week, ahead of a U.S. market holiday. The company raised about $557.2 million net from a stock offering priced at $45 per share and plans to repay $450 million of a seven-year term loan. Viavi reported fiscal Q3 revenue up 42.8% to $406.8 million, while GAAP net income fell 67.2% to $6.4 million.
May 24, 2026
Inflection Point VI’s New Nasdaq Symbols Are Out; $10.15 In Focus This Week
···

Inflection Point VI’s New Nasdaq Symbols Are Out; $10.15 In Focus This Week

Inflection Point Acquisition Corp. VI units closed Friday at $10.15, near their IPO price, as the SPAC’s shares and warrants traded separately in their first week. Class A shares last traded at $10.03, warrants at $0.655. The company raised $253 million in its March IPO, all placed in trust. Nasdaq will remain closed through Memorial Day, with trading set to resume Tuesday.
May 24, 2026
UK & AU Stock Market Today: Live Updates 24.05.2026

UK & AU Stock Market Today: Live Updates 24.05.2026

LIVEMarkets rolling coverageStarted: May 24, 2026, 4:00 AM EDTUpdated: May 24, 2026, 10:20 AM EDT DroneShield ASX:DRO Valuation Examined Amid ASIC Governance Probe May 24, 2026, 10:03 AM EDT. DroneShield (ASX:DRO) faces a formal probe by the Australian Securities and Investments Commission (ASIC) into its November 2025 disclosures and share trading, raising governance concerns. The stock gained 1% in one day but fell 18.6% over 30 days, despite a 151.5% total shareholder return over the past year. Trading at A$3.03, it stands 28% below analyst price targets, with a price-to-sales (P/S) ratio of 12.9x, exceeding sector averages. Analysts debate its
May 24, 2026
Coinbase Layoffs: 700 Jobs Cut as Brian Armstrong Bets on AI in Crypto Slowdown
····

Coinbase Dips Ahead of Holiday; Catalyst Could Hit Soon

Coinbase Global shares fell 4.4% Friday to $184.99, ending the week down 5.3% as the SEC delayed a plan to allow trading of tokenized stocks. The drop came despite Wall Street gains, with crypto-linked stocks lagging as bitcoin and ether prices remained volatile. Coinbase recently reported a $394.1 million quarterly loss and announced 700 job cuts. U.S. markets will be closed Monday for Memorial Day.
May 24, 2026
NovoCure Stock Still Up Ahead of Cancer Trial Data
···

NovoCure Stock Still Up Ahead of Cancer Trial Data

NovoCure shares closed at $17.96 Friday, up 0.3%, and slipped to $17.71 after hours ahead of the Memorial Day market closure. The stock remains about 50% above its April 29 close, after the company raised its 2026 revenue forecast and reported Q1 revenue of $174.1 million. NovoCure had 4,791 active patients at March’s end, including 83 on its new pancreatic cancer device.
May 24, 2026
Sinclair Shares Rise at Week’s End, Attention Turns to Next Week’s Trading
···

Sinclair Shares Rise at Week’s End, Attention Turns to Next Week’s Trading

Sinclair Inc. shares closed at $13.86 Friday, up 1.76% but down 1.1% for the week after a sharp Tuesday drop, lagging broader indexes. The company declared a 25-cent quarterly dividend, payable June 9 to holders as of May 26. Nasdaq will close Monday for Memorial Day. Sinclair reported Q1 revenue of $807 million, up 4% year-over-year, and reaffirmed 2026 guidance.
May 24, 2026
Skye Bioscience Rallies; Holiday Week Puts Focus on Tuesday
···

Skye Bioscience Rallies; Holiday Week Puts Focus on Tuesday

Skye Bioscience shares rose 16% to $0.8293 Friday after a safety panel cleared a higher-dose cohort in its nimacimab obesity-drug study. The stock’s gain contrasted with a sector decline and comes ahead of a Nasdaq closure for Memorial Day. No neuropsychiatric adverse events were reported in the first cohort. Skye expects top-line data from the CBeyond Expansion Study in the fourth quarter.
May 24, 2026
Avidbank Stock’s Quiet Weekly Climb Leaves One Bigger Test After the Long Weekend
···

Avidbank Stock’s Quiet Weekly Climb Leaves One Bigger Test After the Long Weekend

Avidbank Holdings shares closed at $29.91 Friday, up 2.19% for the week, ahead of the Memorial Day market closure. Shareholders re-elected all 10 board nominees and ratified Crowe LLP as auditor at the May 19 annual meeting. First-quarter net income was $9.0 million, with net interest margin at 4.38%. Deposits grew, including a $38.5 million increase in brokered deposits.
May 23, 2026
Almonty shares up close to 7% this week
····

Almonty shares up close to 7% this week

Almonty Industries’ Nasdaq shares closed Friday at $18.66, down 0.69% on the day but up nearly 7% for the week amid strong demand for non-Chinese tungsten supply. The U.S. market will remain closed Monday for Memorial Day, with trading set to resume Tuesday. Almonty reported Q1 revenue of $25.4 million, a 221% increase, but posted a net loss of $5.3 million. The stock remains in focus after EU stockpile plans and record tungsten prices.
May 23, 2026
Aemetis Jumps 19% Heading Into Holiday Break
···

Aemetis Jumps 19% Heading Into Holiday Break

Aemetis shares surged 19.1% Friday to $2.68 after California officials advanced a step toward possible $1.1 billion in tax-exempt bonds for company projects. Trading volume hit 3.23 million shares. Ascendiant Capital raised its price target to $22. Nasdaq will be closed through Memorial Day, with trading set to resume Tuesday.
May 23, 2026
All eyes on Autodesk ahead of earnings
···

All eyes on Autodesk ahead of earnings

Autodesk shares closed Friday at $240.99, up 0.33% for the day and 1.9% for the week. U.S. markets are closed for Memorial Day on Monday, leaving three trading days before Autodesk reports fiscal Q1 earnings after the close on May 28. The company has forecast revenue of $1.885–$1.900 billion and non-GAAP EPS of $2.82–$2.86.
May 23, 2026
1 2 3 … 339

Stock Market Today

  • DroneShield ASX:DRO Valuation Examined Amid ASIC Governance Probe
    May 24, 2026, 10:03 AM EDT. DroneShield (ASX:DRO) faces a formal probe by the Australian Securities and Investments Commission (ASIC) into its November 2025 disclosures and share trading, raising governance concerns. The stock gained 1% in one day but fell 18.6% over 30 days, despite a 151.5% total shareholder return over the past year. Trading at A$3.03, it stands 28% below analyst price targets, with a price-to-sales (P/S) ratio of 12.9x, exceeding sector averages. Analysts debate its valuation, with some seeing a fair value of A$8.57 based on recurring institutional contracts, while others caution on risks including procurement delays. Investors are advised to weigh growth potential against regulatory risks amid global defense spending expansion.